From Fear to Purpose ACT Protocol. Implications of Death Anxiety in Depression and Anxiety Symptoms.
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorBabes-Bolyai University
About this trial
The main purpose of this placebo controlled trial is to test the efficacy of a one-session From Fear to Purpose ACT intervention in reducing self-reported death anxiety levels. Another objective of this study is to investigate whether reductions in death anxiety levels are associated with reductions in depression and anxiety levels, thus testing if death anxiety is a transdiagnostic factor involved in psychopathology.
Eligibility criteria
Qualifiers
Moderate-high levels of death anxiety (score > or = 55) AND
Subclinical levels of depression (score > or = 9) AND/OR
Subclinical levels of anxiety (score > or = 9)
Disqualifiers
Minors
Suicidal ideation
Current psychological/psychiatric diagnosis (except depression or anxiety diagnosis)
Active psychological/psychiatric treatment
Trial design
Treatments tested in this trial
- From Fear to Purpose (Acceptance and Commitment Therapy)
- Placebo
Treatment groups
175 Participants
are divided into 2 treatment groupsLocations
This trial has no locations
Sponsors and collaborators
Babes-Bolyai University
Lead sponsor
Source ClinicalTrials.gov